Gain Therapeutics, Inc. (GANX): Weighted Average Diluted Shares
32.97M
Year ended 2025-12-31
+40.5%
3-year compound annual growth
+65.2%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 32.97M | +44.1% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | 22.88M | +75.9% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | 13.01M | +9.5% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | 11.88M | +16.9% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | 10.17M | +279.1% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | 2.68M | n/a | 2022-03-25, From 2020-01-01 |